News Archives - PsychoGenics

PsychoGenics Chief Innovation Officer Honored for Scientific Excellence

by Eric | Oct 11, 2021

Read more: https://www.businesswire.com/news/home/20210923005825/en/PsychoGenics-Chief-Innovation-Officer-Honored-for-Scientific-Excellence

PsychoGenics Further Strengthens its Leadership Team, Adding Three Senior Executives

by Maxson | Sep 25, 2020

PsychoGenics Further Strengthens its Leadership Team, Adding Three Senior Executives

PsychoGenics Drug Discovery Featured in Nature Biopharma Dealmakers

by Maxson | Sep 16, 2020

Karuna Therapeutics and PsychoGenics Announce Drug Discovery Collaboration

by Maxson | Jul 28, 2020

PsychoGenics Awarded NIH HEAL Initiative Contract for Preclinical Screening Platform for Pain (PSPP)

by admin | Nov 6, 2019

PARAMUS, N.J., November 6, 2019 – PGI Holding Corporation (PsychoGenics) announced that it has been awarded an Indefinite Delivery Indefinite Quantity contract by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National...

PsychoGenics Chief Innovation Officer Honored for Scientific Excellence

PsychoGenics Further Strengthens its Leadership Team, Adding Three Senior Executives

PsychoGenics Drug Discovery Featured in Nature Biopharma Dealmakers

Karuna Therapeutics and PsychoGenics Announce Drug Discovery Collaboration

PsychoGenics Awarded NIH HEAL Initiative Contract for Preclinical Screening Platform for Pain (PSPP)

Recent Comments

CONTACT

Email: info@psychogenics.com

Phone: (914) 406-8019